BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20962042)

  • 1. Prolactin inhibits activity of pyruvate kinase M2 to stimulate cell proliferation.
    Varghese B; Swaminathan G; Plotnikov A; Tzimas C; Yang N; Rui H; Fuchs SY
    Mol Endocrinol; 2010 Dec; 24(12):2356-65. PubMed ID: 20962042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of transient signaling via short and long prolactin receptor isoforms in female and male sensory neurons.
    Belugin S; Diogenes AR; Patil MJ; Ginsburg E; Henry MA; Akopian AN
    J Biol Chem; 2013 Nov; 288(48):34943-55. PubMed ID: 24142695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Human Intermediate Prolactin Receptor I-tail Contributes Breast Oncogenesis by Targeting Ras/MAPK Pathway.
    Shen S; Radhakrishnan SK; Harrell JC; Puchalapalli M; Koblinski J; Clevenger C
    Endocrinology; 2024 Apr; 165(6):. PubMed ID: 38713636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyruvate kinase M2 expression, but not pyruvate kinase activity, is up-regulated in a grade-specific manner in human glioma.
    Mukherjee J; Phillips JJ; Zheng S; Wiencke J; Ronen SM; Pieper RO
    PLoS One; 2013; 8(2):e57610. PubMed ID: 23451252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Mechanism of hPRL-G129R, a Prolactin Antagonist, Inhibits Human Breast Cancer Cell Proliferation and Migration.
    Li R; Yang Y; Lan H; Wang Y; Ge Z; Liu X; Zhou Y; Zhang W; Xian L; Yuan H
    Endocrinology; 2023 Nov; 164(12):. PubMed ID: 37934803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AKT-induced PKM2 phosphorylation signals for IGF-1-stimulated cancer cell growth.
    Park YS; Kim DJ; Koo H; Jang SH; You YM; Cho JH; Yang SJ; Yu ES; Jung Y; Lee DC; Kim JA; Park ZY; Park KC; Yeom YI
    Oncotarget; 2016 Jul; 7(30):48155-48167. PubMed ID: 27340866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PKM2 contributes to cancer metabolism.
    Wong N; Ojo D; Yan J; Tang D
    Cancer Lett; 2015 Jan; 356(2 Pt A):184-91. PubMed ID: 24508027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinoma.
    Liu AM; Xu Z; Shek FH; Wong KF; Lee NP; Poon RT; Chen J; Luk JM
    PLoS One; 2014; 9(1):e86872. PubMed ID: 24466275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proviral insertion in murine lymphomas 2 (PIM2) oncogene phosphorylates pyruvate kinase M2 (PKM2) and promotes glycolysis in cancer cells.
    Yu Z; Zhao X; Huang L; Zhang T; Yang F; Xie L; Song S; Miao P; Zhao L; Sun X; Liu J; Huang G
    J Biol Chem; 2013 Dec; 288(49):35406-16. PubMed ID: 24142698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression.
    Goldberg MS; Sharp PA
    J Exp Med; 2012 Feb; 209(2):217-24. PubMed ID: 22271574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyruvate kinase expression (PKM1 and PKM2) in cancer-associated fibroblasts drives stromal nutrient production and tumor growth.
    Chiavarina B; Whitaker-Menezes D; Martinez-Outschoorn UE; Witkiewicz AK; Birbe R; Howell A; Pestell RG; Smith J; Daniel R; Sotgia F; Lisanti MP
    Cancer Biol Ther; 2011 Dec; 12(12):1101-13. PubMed ID: 22236875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses.
    Anastasiou D; Poulogiannis G; Asara JM; Boxer MB; Jiang JK; Shen M; Bellinger G; Sasaki AT; Locasale JW; Auld DS; Thomas CJ; Vander Heiden MG; Cantley LC
    Science; 2011 Dec; 334(6060):1278-83. PubMed ID: 22052977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-Guided Approach to Discover Tuberosin as a Potent Activator of Pyruvate Kinase M2, Targeting Cancer Therapy.
    Adnan M; Shamsi A; Elasbali AM; Siddiqui AJ; Patel M; Alshammari N; Alharethi SH; Alhassan HH; Bardakci F; Hassan MI
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research progress on the role of PKM2 in the immune response.
    Liu C; Liu C; Fu R
    Front Immunol; 2022; 13():936967. PubMed ID: 35967360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttranslational modification of pyruvate kinase type M2 (PKM2): novel regulation of its biological roles to be further discovered.
    Zheng S; Liu Q; Liu T; Lu X
    J Physiol Biochem; 2021 Aug; 77(3):355-363. PubMed ID: 33835423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyruvate Kinase M2 and Cancer: The Role of PKM2 in Promoting Tumorigenesis.
    Zahra K; Dey T; Ashish ; Mishra SP; Pandey U
    Front Oncol; 2020; 10():159. PubMed ID: 32195169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical review of the role of M
    Harris RA; Fenton AW
    Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):225-239. PubMed ID: 30708038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyruvate Kinase Inhibits Proliferation during Postnatal Cerebellar Neurogenesis and Suppresses Medulloblastoma Formation.
    Tech K; Tikunov AP; Farooq H; Morrissy AS; Meidinger J; Fish T; Green SC; Liu H; Li Y; Mungall AJ; Moore RA; Ma Y; Jones SJM; Marra MA; Vander Heiden MG; Taylor MD; Macdonald JM; Gershon TR
    Cancer Res; 2017 Jun; 77(12):3217-3230. PubMed ID: 28515149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyruvate kinase: Function, regulation and role in cancer.
    Israelsen WJ; Vander Heiden MG
    Semin Cell Dev Biol; 2015 Jul; 43():43-51. PubMed ID: 26277545
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.